Hexoprenaline

Jump to navigation Jump to search
Hexoprenaline
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H32N2O6
Molar mass420.499 g/mol
3D model (JSmol)

WikiDoc Resources for Hexoprenaline

Articles

Most recent articles on Hexoprenaline

Most cited articles on Hexoprenaline

Review articles on Hexoprenaline

Articles on Hexoprenaline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hexoprenaline

Images of Hexoprenaline

Photos of Hexoprenaline

Podcasts & MP3s on Hexoprenaline

Videos on Hexoprenaline

Evidence Based Medicine

Cochrane Collaboration on Hexoprenaline

Bandolier on Hexoprenaline

TRIP on Hexoprenaline

Clinical Trials

Ongoing Trials on Hexoprenaline at Clinical Trials.gov

Trial results on Hexoprenaline

Clinical Trials on Hexoprenaline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hexoprenaline

NICE Guidance on Hexoprenaline

NHS PRODIGY Guidance

FDA on Hexoprenaline

CDC on Hexoprenaline

Books

Books on Hexoprenaline

News

Hexoprenaline in the news

Be alerted to news on Hexoprenaline

News trends on Hexoprenaline

Commentary

Blogs on Hexoprenaline

Definitions

Definitions of Hexoprenaline

Patient Resources / Community

Patient resources on Hexoprenaline

Discussion groups on Hexoprenaline

Patient Handouts on Hexoprenaline

Directions to Hospitals Treating Hexoprenaline

Risk calculators and risk factors for Hexoprenaline

Healthcare Provider Resources

Symptoms of Hexoprenaline

Causes & Risk Factors for Hexoprenaline

Diagnostic studies for Hexoprenaline

Treatment of Hexoprenaline

Continuing Medical Education (CME)

CME Programs on Hexoprenaline

International

Hexoprenaline en Espanol

Hexoprenaline en Francais

Business

Hexoprenaline in the Marketplace

Patents on Hexoprenaline

Experimental / Informatics

List of terms related to Hexoprenaline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hexoprenaline (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]

References

  1. Pinder RM, Brogden RN, Speight TM, Avery GS. Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. Drugs. 1977 Jul;14(1):1-28. PMID 195789

Template:WH Template:WS